The serum levels of IL‐8 and S100A4 steadily increased following stage‐by‐stage PCa metastatic progression, suggesting that IL‐8 and S100A4 may serve as metastatic PCa biomarkers beyond PSA (Figure 7B,C). The gene discussed is S100A4; the disease is posterior cortical atrophy.